King Pharmaceuticals' P2P Acquisition

King Pharmaceuticals raised a round of funding on February 28, 2011. Investors include Pfizer.

King Pharmaceuticals researches and develops, manufactures, markets, and sells branded prescription pharmaceutical products and animal health products. In March 2011, King Pharmaceuticals was acquire…

Articles about King Pharmaceuticals' P2P Acquisition: